Equillium (NASDAQ:EQ) Lowered to Hold Rating by Leerink Partnrs
Leerink Partnrs lowered shares of Equillium (NASDAQ:EQ – Free Report) from a strong-buy rating to a hold rating in a research report released on Friday,Zacks.com reports. Leerink Partnrs also issued estimates for Equillium’s FY2029 earnings at ($0.06) EPS. Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $1.00 price objective (down from $3.00) […]
Leerink Partnrs lowered shares of Equillium (NASDAQ:EQ – Free Report) from a strong-buy rating to a hold rating in a research report released on Friday,Zacks.com reports. Leerink Partnrs also issued estimates for Equillium’s FY2029 earnings at ($0.06) EPS. Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $1.00 price objective (down from $3.00) […]
